2020
DOI: 10.1021/acs.orglett.9b04654
|View full text |Cite
|
Sign up to set email alerts
|

Direct and Chemoselective Electrophilic Monofluoromethylation of Heteroatoms (O-, S-, N-, P-, Se-) with Fluoroiodomethane

Abstract: The commercially available fluoroiodomethane represents a valuable and effective electrophilic source for transferring the CH 2 F unit to a series of heteroatom-centered nucleophiles under mild basic conditions. The excellent manipulability offered by its liquid physical state (bp 53.4°C) enables practical and straightforward one-step nucleophilic substitutions to retain the chiral information embodied, thus allowing it to overcome de facto the requirement for fluoromethylating agents with no immediate access.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 61 publications
0
26
0
1
Order By: Relevance
“…Among many fluoroalkyl groups, fluoroalkylthio groups, including the trifluoromethylthio group (−SCF 3 ), difluoromethylthio group (−SCF 2 H), and monofluoromethylthio group (−SCH 2 F), have received special attention, mainly because of their ability to fine-tune the drug molecule’s pharmacokimetic and pharmacodynamic properties. While a variety of efficient methods for the introduction of the trifluoromethylthio and difluoromethylthio groups have been reported in the past 10 years, methods for the incorporation of the monofluoromethylthio group are limited. Notably, the drugs fluticasone, which is a steroid to treat nasal symptoms, and fluticasone propionate, which is used for long-term management of asthma, contain a monofluoromethylthio group (Figure ). …”
Section: Introductionmentioning
confidence: 79%
“…Among many fluoroalkyl groups, fluoroalkylthio groups, including the trifluoromethylthio group (−SCF 3 ), difluoromethylthio group (−SCF 2 H), and monofluoromethylthio group (−SCH 2 F), have received special attention, mainly because of their ability to fine-tune the drug molecule’s pharmacokimetic and pharmacodynamic properties. While a variety of efficient methods for the introduction of the trifluoromethylthio and difluoromethylthio groups have been reported in the past 10 years, methods for the incorporation of the monofluoromethylthio group are limited. Notably, the drugs fluticasone, which is a steroid to treat nasal symptoms, and fluticasone propionate, which is used for long-term management of asthma, contain a monofluoromethylthio group (Figure ). …”
Section: Introductionmentioning
confidence: 79%
“…The monofluoromethyl group has been less explored due to the intrinsic instability of the monofluoromethyl carbanion, which has a fleeting existence and rapidly decomposes at −78 °C to a carbene through the elimination of lithium fluoride. Recently, Luisi and Pace reported the first conditions to generate fluoromethyllithium in situ in the presence of electrophiles from fluoroiodomethane. , Inspired by this new methodology for nucleophilic monofluoromethylation, we conducted a trial reaction with the Weinreb amide 29 . The dropwise addition of MeLi·LiBr to a solution of FCH 2 I and 29 in 1:1 THF/Et 2 O at −78 °C using the reported optimized stoichiometry of 1:2:1.5 FCH 2 I/MeLi·LiBr/ 29 furnished the bromomethylketone 32 (Scheme ; page S2 in the SI), indicating that competitive halogen scrambling was occurring.…”
Section: Resultsmentioning
confidence: 99%
“…The direct/full chemoselective conversion of a ketone into the homologated all-carbon quaternary aldehyde (Figure 6a) [33] and the telescoped homologation of imine surrogates to quaternary aziridines (Figure 6b) [34] will illustrate these unprecedented concepts. Additionally, the one-step mono-fluoromethylation of carbon electrophiles with extremely labile fluoromethyllithium reagents will provide a novel entry to valuable fluorinated building-blocks without the need to use protecting elements for fluoro-containing carbanions (Figure 6c) [35][36][37]. Moreover, novel strategies for introducing the difluoromethyl group through the proper activation of commercially available TMSCHF 2 with an alkoxide will be discussed [38,39].…”
Section: Vittorio Pace Laura Ielo Margherita Miele and Raffaele Senatorementioning
confidence: 99%